journal article·2018-11-05Open access

Biodegradable hybrid-structured nanofibrous membrane supported chemoprotective gene therapy enhances chemotherapy tolerance and efficacy in malignant glioma rats

Shih-Jung Liu, Tao-Chieh Yang, Shun-Tai Yang, Ying-Chun Chen, Yuan-Yun Tseng

Abstract

-BG in the early phase, followed by high levels of two alkylators. All drug concentrations remained high for over 14 weeks. Tumour growth was slower and the mean survival time was significantly prolonged in the HSNM-treated group. Biodegradable HSNMs can enhance therapeutic efficacy and prevent toxic systemic effects.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Glioma Diagnosis and Treatment · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Mechanical Engineering, Chang Gung University, Tao-Yuan, Taiwan, ROC;

Department of Orthopedic Surgery, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan, ROC;

Department of Neurosurgery, Asia University Hospital, Taichung, Taiwan, ROC;

Division of Neurosurgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan, ROC;

Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC

Funding

National Science Council of Taiwan · Chang Gung Memorial Hospital

References (51)

Show source-provided references
1. 10.1038/nrclinonc.2012.20410.1038/nrclinonc.2012.204 ↗
2. 10.1172/JCI7673910.1172/JCI76739 ↗
3. 10.1056/NEJMoa04333010.1056/NEJMoa043330 ↗
4. 10.1200/JCO.2007.11.855410.1200/JCO.2007.11.8554 ↗
5. 10.1200/JCO.2005.06.50210.1200/JCO.2005.06.502 ↗
6. 10.1200/JCO.2008.18.841710.1200/JCO.2008.18.8417 ↗
7. Dolan ME · Cancer Res · 1991 · 51 · 3367
8. Bacolod MD · Mol Cancer Ther · 2002 · 1 · 727
9. 10.1200/JCO.2004.06.18110.1200/JCO.2004.06.181 ↗
10. 10.3171/jns.1988.68.1.000110.3171/jns.1988.68.1.0001 ↗
11. Rhines LD · Cancer Res · 2000 · 60 · 6307
12. 10.1016/S0140-6736(95)90755-610.1016/S0140-6736(95)90755-6 ↗
13. 10.1016/j.colsurfb.2015.06.05510.1016/j.colsurfb.2015.06.055 ↗
14. 10.3171/jns.1992.76.4.064010.3171/jns.1992.76.4.0640 ↗
15. 10.1093/neuonc/5.2.7910.1093/neuonc/5.2.79 ↗
16. 10.1158/0008-5472.CAN-05-071510.1158/0008-5472.CAN-05-0715 ↗
17. 10.1158/1535-7163.MCT-11-080110.1158/1535-7163.MCT-11-0801 ↗
18. 10.1158/0008-5472.CAN-04-333510.1158/0008-5472.CAN-04-3335 ↗
19. 10.1215/15228517-2008-07510.1215/15228517-2008-075 ↗
20. 10.1586/ern.10.3210.1586/ern.10.32 ↗
21. 10.1215/15228517-2008-09010.1215/15228517-2008-090 ↗
22. 10.1158/1078-0432.CCR-08-213010.1158/1078-0432.CCR-08-2130 ↗
23. 10.1002/cncr.2439810.1002/cncr.24398 ↗
24. 10.2147/IJN.S10725010.2147/IJN.S107250 ↗
25. 10.1007/s11910-011-0184-010.1007/s11910-011-0184-0 ↗
26. 10.1158/0008-5472.CAN-10-090610.1158/0008-5472.CAN-10-0906 ↗
27. 10.18632/oncotarget.1098910.18632/oncotarget.10989 ↗
28. 10.1080/21691401.2016.122865810.1080/21691401.2016.1228658 ↗
29. Tamargo RJ · Cancer Res · 1993 · 53 · 329
30. Bota DA · Ther Clin Risk Manag · 2007 · 3 · 707
31. 10.3109/21691401.2015.105246710.3109/21691401.2015.1052467 ↗
32. Bocangel DB · Clin Cancer Res · 2002 · 8 · 2725
33. Bobola MS · Clin Cancer Res · 1996 · 2 · 735
34. Friedman HS · Cancer Res · 1995 · 55 · 2853
35. 10.1007/s00280005057710.1007/s002800050577 ↗
36. 10.1200/JCO.2000.18.20.352210.1200/JCO.2000.18.20.3522 ↗
37. 10.1200/JCO.2006.06.629010.1200/JCO.2006.06.6290 ↗
38. 10.1200/JCO.2002.09.08410.1200/JCO.2002.09.084 ↗
39. 10.1215/15228517-2009-00710.1215/15228517-2009-007 ↗
40. 10.1007/s11060-006-9244-810.1007/s11060-006-9244-8 ↗
41. 10.1517/17425247.5.2.15510.1517/17425247.5.2.155 ↗
42. 10.1517/1742524090293914310.1517/17425240902939143 ↗
43. 10.1080/21691401.2016.120226010.1080/21691401.2016.1202260 ↗
44. 10.1080/21691401.2017.137667510.1080/21691401.2017.1376675 ↗
45. 10.1007/s11095-008-9697-x10.1007/s11095-008-9697-x ↗
46. 10.1517/17425247.2013.75810210.1517/17425247.2013.758102 ↗
47. 10.1080/21691401.2018.144394010.1080/21691401.2018.1443940 ↗
48. 10.3390/polym303137710.3390/polym3031377 ↗
49. 10.1016/0142-9612(95)93575-X10.1016/0142-9612(95)93575-X ↗
50. 10.2147/IJN.S12459310.2147/IJN.S124593 ↗
51. 10.1038/srep3063010.1038/srep30630 ↗